Connect with us

National

Zimbabwe ivory trade lobby raises questions

Published

on

BY NOKUTHABA DLAMINI

Zimbabwe’s aggressive lobbying to overturn a global ban on the sale of ivory has raised more questions than answers with conservationists arguing that the country’s claims that it has stockpiles worth US$600 million are an exaggeration.

Advertisement

The southern African country is hosting a three-day conference where it invited 15 nations to push for the legalisation of ivory trade to finance conservation efforts.

Ahead of the conference, the government showcased its ivory stockpiles at a warehouse just outside the capital Harare to European Union diplomats where officials said the country had the potential to earn US$600 million if it is allowed to sell the stocks.

The position, however, is proving to be a tough sale for some conservation experts attending the conference being held at the Hwange National Park, Zimbabwe’s biggest game reserve, which is home to the largest population of elephants in the country.

Advertisement

A number of conservationists said Zimbabwe’s claims did not make sense given the fact that the highest price for worked ivory on sale in the market around 2015 was US$ 2 100 per kilogramme, and the price has since crashed. The wholesale price of raw ivory is estimated to be US$150 per kilogramme.

At that price, even if Zimbabwe were able to sell its entire 130 tonnes of stockpiled ivory, it would earn only roughly US$20m.

Zimbabwe has threatened to quit the Convention on International Trade in Endangered Species (CITES) if the trade ban is not lifted.

Advertisement

CITES banned the sale of ivory in 1998 to save elephants from extinction due to widespread poaching.

“The figures don’t make sense,” said a South African conservationist on the side lines of the conference.

“Most of these countries are using a rate, which was set in 2008 and it was quite high at US$167 per kilogramme, but figures have gone down because the (Asian) countries they are targeting (as the potential markets) bought the ivory at that time and they are still consuming the old stock.”

Advertisement

The conservationist said the formal ivory markets that countries such as Zimbabwe were targeting were saturated.

China, which used to be the biggest buyer for legal ivory, has banned all trade, as has Vietnam.

Japan, which bought ivory in the past, still has large amounts from earlier one-off sales.

Advertisement

“These Asian countries that they are targeting have no room for extra stocks,” he added.

“The other observation is that these countries are evaluating their stocks using pricing that is exaggerated and that on its own has created some confusion.”

Another southern African conservationist said countries should be focusing on reforms within CITES to help fund conservation work.

Advertisement

Leaving CITES would not allow them to sell ivory as buyers would also have to leave the international organisation, which would affect trade in many other wildlife and plant species.

“There is no money from these governments to deal with conservation, so it’s a question of them asking where they can get money,” he said.

“Zimbabwe has threatened to withdraw from CITES if not heard, but the challenge with that is that they can be selling those stockpiles illegally and the Asian buyers that they are targeting that is China, Vietnam, Japan are members of CITES.

Advertisement

“The danger is that those countries (who are potential buyers) should also pull out (of CITES) so that they both illegally trade, and such will have implications on the credibility of the state.

“Countries should have other ways of making money, whereby they can go through issues of quantifying their carbon sale and we believe that they can get something larger than what they are advocating for in the sale of ivory at a price that is unapproved.

“Most of these countries have issues with their economies so they are hoping that if they sell some of the money will go into conservation and addressing human-wildlife conflicts, but they have not told us how they want to use the money in a way that’s transparent and convincing apart from saying they want to sell.”

Advertisement

Fulton Mangwanya, Zimbabwe National Parks and Wildlife Management Authority (Zimparks) director general, insisted that ivory was undervalued on the international market.

“The value of a kilogramme is usually US$15 000, and I don’t know the values that others have, but irrespective of that figure I am talking about all we are saying is we want to unlock the value of that same stock-pile we have,” Mangwanya told VicFallsLive at the conference.

“We want to eat what we should, so this is what we are pushing especially after Covid-19 which has ravaged everything, and the revenue streams are dry.

Advertisement

“So the best we can do is to leverage on the stockpiles that we have because they have so much value in the markets.”

He said there were countries that were ready to buy Zimbabwe’s ivory.

“If the ban is lifted Asian countries are actually interested in our ivory,” Mangwanya added, without naming which countries he was referring to.

Advertisement

“So it is not a matter of marketing because they are still on and they are still trading in ivory locally and they are getting all these imports from poachers who are into trafficking because to them, it’s a cultural industry that can never be closed.

“It’s not a secret that the market is still there and we are only being blocked by CITES.”

One Kenya-based conservation source highlighted that China closed its market on the order of its central government, not because of CITES.

Advertisement

“It is a major distraction from the real issues of conservation finance to suggest ivory can be sold again,” he said.

“China will not open its markets again, so any sale is only going to finance the illicit trade that spurred the poaching surge a decade ago.”

Zimbabwe says its elephant population has become unsustainable because of good conservation programmes.

Advertisement

Southern African countries have in recent years seen their elephant populations grow significantly and they are now home to about 70 percent of Africa’s elephants.

Zimbabwe is estimated to be home to 100 000 elephants, the second highest population after Botswana, and the wildlife authorities say the figure is double what the country’s game reserves can hold.

Zimparks says the elephant population explosion is also fuelling human-wildlife conflict.

Advertisement

Zimbabwe last month said 64 people were killed by wild animals since the beginning of the year.

Mangwanya said with more money to fund conservation, the country would be able to prevent the deaths.

“Whichever figure comes with the same funds; we want to unlock the value so that we use the same funds to improve the livelihoods of the 55 districts of communities who are living with the animals,” he said.

Advertisement

“Countries without species like elephants should not comment about it as long as they are not directly affected because these are issues that we are trying to put across and we expect the same to be accepted at CITES if we don’t have unnecessary opposition from our brother and sisters’ African states.”

A bloc of 28 African countries including Kenya, Gabon, and most West and Central African countries oppose proposals to lift the ban on ivory trade, which they fear would encourage more poaching.

A group of 50 anti-ivory trade organisations warned that opening the ivory market would pose a serious danger to the African herd.

Advertisement

“The conference is sending a dangerous signal to poachers and criminal syndicates that elephants are mere commodities and that ivory trade could be resumed, heightening the threat to the species,” the groups said.

Advertisement
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

National

World AIDS Day: UN Chief says ending AIDS by 2030 “is within grasp”

Published

on

BY SONIA HLOPHE

United Nations Secretary-General António Guterres has marked World AIDS Day with a message urging world leaders to scale up investment, confront stigma and ensure that lifesaving HIV services reach everyone who needs them.

Advertisement

In his statement, Guterres said this year’s commemoration serves as a reminder that the world “has the power to transform lives and futures, and end the AIDS epidemic once and for all.”

He highlighted the major gains achieved over the past decade.

“The progress we have made is undeniable,” he said, noting that “since 2010, new infections have fallen by 40 per cent” while “AIDS-related deaths have declined by more than half.” Access to treatment, he added, “is better than ever before.”

Advertisement

But despite this global progress, the Secretary-General warned that the crisis is far from over.

“For many people around the world, the crisis continues,” he said. “Millions still lack access to HIV prevention and treatment services because of who they are, where they live or the stigma they endure.”

Guterres also raised concern over shrinking resources:

Advertisement

“Reduced resources and services are putting lives at risk and threatening hard-won gains.”

He said ending AIDS requires fully supporting communities, scaling up prevention and ensuring treatment for everyone.

“Ending AIDS means empowering communities, investing in prevention and expanding access to treatment for all people.”

Advertisement

He also called for innovation to be matched by real-world delivery:

“It means uniting innovation with action, and ensuring new tools like injectables reach more people in need.”

Above all, he stressed the need for a human-rights centred response so no one is excluded.

Advertisement

“At every step, it means grounding our work in human rights to ensure no one is left behind.”

With the 2030 global deadline approaching, the UN chief said success is still possible if momentum is sustained.

“Ending AIDS as a public health threat by 2030 is within grasp. Let’s get the job done.”

Advertisement

 

Advertisement
Continue Reading

National

Zimbabwe fast-tracks approval of long-acting HIV prevention drug Lenacapavir

Published

on

BY WANDILE TSHUMA

Zimbabwe has taken a major step in the fight against HIV following the rapid approval of Lenacapavir, a groundbreaking long-acting injectable for HIV pre-exposure prophylaxis (PrEP). The Medicines Control Authority of Zimbabwe (MCAZ) authorised the drug in just 23 days, marking one of the fastest regulatory approvals in the country’s history.

Advertisement

The application, submitted by pharmaceutical company Gilead Sciences in October, underwent an expedited review because of its public health importance. MCAZ says the fast-tracked process did not compromise scientific scrutiny, with the product subjected to a rigorous assessment of its safety, efficacy and quality.

Lenacapavir is designed for adults and adolescents weighing at least 35kg who are HIV-negative but at substantial risk of infection. Unlike traditional daily oral PrEP, the medicine is administered as a six-monthly injection, following an initiation phase that includes one injection and oral tablets on Days 1 and 2. Health authorities say this long-acting formulation could dramatically improve adherence and expand prevention options, particularly for communities where daily pill-taking is difficult.

MCAZ Director-General  Richard T. Rukwata described the approval as a landmark moment in Zimbabwe’s HIV response.

Advertisement

“The rapid approval of Lenacapavir reflects MCAZ’s dedication to accelerating access to trusted, high-quality health products. This milestone brings new hope for HIV prevention and reinforces our commitment to safeguarding public health,” he said.

To fast-track the process, the Authority applied a regulatory reliance approach, drawing on scientific assessments from the World Health Organization’s Prequalification Programme (WHO PQ). This allowed evaluators to build on internationally recognised review processes while ensuring Zimbabwe’s own standards were met.

The introduction of Lenacapavir comes as Zimbabwe continues efforts to reduce new HIV infections, particularly among young people and key populations who face barriers to consistent PrEP use. Public health experts say the drug’s twice-yearly dosing could be a game changer in improving uptake and protection.

Advertisement

MCAZ says it remains committed to ensuring Zimbabweans have access to safe, effective and good-quality medical products, in line with its mandate under the Medicines and Allied Substances Control Act.

Advertisement
Continue Reading

National

Zimbabwe makes gains against TB

Published

on

BY WANDILE TSHUMA

The World Health Organization (WHO) data show that Zimbabwe continues to make measurable gains in its fight against tuberculosis (TB).

Advertisement

According to the Global Tuberculosis Report 2025, Zimbabwe’s estimated TB incidence has declined to 203 per 100,000 population, representing a 3.8 % reduction from 2023. The report states that “TB incidence in Zimbabwe has fallen to 203 per 100 000, a 3.8 % reduction from 2023.” 

On treatment outcomes, the country’s overall success rate for all forms of TB has improved to 91 %, up from 89 % in 2023. The report quotes: “Treatment success for all forms of TB has improved to 91 %, up from 89 % in 2023.” 

For drug-resistant TB (DR-TB), progress has also been recorded: treatment success rose from 64 % for the 2021 cohort to 68 % for the 2022 cohort. As the report notes: “treatment success for drug-resistant TB increased from 64 % for the 2021 cohort to 68 % for the 2022 cohort.” 

Advertisement

In the critical sphere of TB‐HIV co-infection, Zimbabwe saw a drop in the co‐infection rate to 49 %, down from 51 %. The report states: “TB/HIV co-infection rates have fallen to 49 %, down from 51 %.” 

Zooming out, the 2025 global report shows that across the world TB is falling again, although not yet at the pace required to meet targets. Globally, incidence declined by almost 2 % between 2023 and 2024, and deaths fell around 3 %. 

However, the report warns that progress is fragile. Funding shortfalls, health-system disruptions (especially during the COVID-19 era), and the ongoing challenge of drug-resistant TB threaten to erode gains. The WHO page reminds that the 2025 edition “provides a comprehensive … assessment of the TB epidemic … at global, regional and country levels.” 

Advertisement

For example, although more people are being diagnosed and treated than in previous years, not enough are being reached with preventive interventions, and many countries are still far from the targets set under the End TB Strategy.

 

Advertisement
Continue Reading

Trending

Copyright © 2022 VicFallsLive. All rights reserved, powered by Advantage